The human plasminogen activator inhibitor type I gene promoter targets to kidney

被引:6
作者
Emert, MP
Sorenson, CM
Basile, DP
Rogers, JG
Hammerman, MR
Billadello, JJ
机构
[1] Washington Univ, Sch Med, Dept Med, Div Cardiovasc, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, George M OBrien Ctr,Renal Div, St Louis, MO 63110 USA
关键词
outer medulla; SQ segment; transforming growth factor-beta;
D O I
10.1152/ajprenal.1998.274.2.F405
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The plasminogen activator inhibitor type 1 (PAI-1) gene encodes the physiological inhibitor of tissue-type and urokinase-type plasminogen activators and is induced by cytokines such as transforming growth factor-beta (TGF-beta). Studies have identified DNA sequence elements within the first 1.3 kb of the 5'-upstream DNA that mediate cytokine responsiveness in transfected cells in vitro. However, the DNA sequences that mediate PAI-1 expression in vivo have not yet been delineated. To define these regulatory sequences, we generated transgenic mice that expressed a hybrid gene comprising sequences between -1,272 and +75 of the human PAI-1 gene ligated to a LacZ reporter gene. Transgene expression detected in two independent lines was observed only in kidney from embryonic day 13 to adult and was seen primarily in proximal tubule cells of the outer medulla. Transgene expression and activity were unchanged in response to TGF-beta and remained restricted to kidney. Thus we have identified a promoter region within the PAI-1 gene that targets transgene expression to kidney but, unlike the native promoter, is unresponsive to TGF-beta in the experimental protocol used.
引用
收藏
页码:F405 / F412
页数:8
相关论文
共 30 条
  • [1] EXPRESSION OF PLASMINOGEN ACTIVATOR-INHIBITOR-1 (PAI-1) DURING CELLULAR REMODELING IN PROLIFERATIVE GLOMERULONEPHRITIS IN THE RAT
    BARNES, JL
    MITCHELL, RJ
    TORRES, ES
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1995, 43 (09) : 895 - 905
  • [2] Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury
    Basile, DP
    Rovak, JM
    Martin, DR
    Hammerman, MR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 270 (03): : F500 - F509
  • [3] ROLE OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 IN THE PATHOGENESIS AND OUTCOME OF THE HEMOLYTIC UREMIC SYNDROME
    BERGSTEIN, JM
    RILEY, M
    BANG, NU
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) : 755 - 759
  • [4] DARPP-32 PROMOTER DIRECTS TRANSGENE EXPRESSION TO RENAL THICK ASCENDING LIMB OF LOOP OF HENLE
    BLAU, S
    DALY, L
    FIENBERG, A
    TEITELMAN, G
    EHRLICH, ME
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (04): : F564 - F570
  • [5] BRUCE C, 1996, GENE, V178, P157
  • [6] DESCHEEMAEKER KA, 1992, J BIOL CHEM, V267, P15086
  • [7] Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta 1 responsiveness in endothelium in vivo
    Dong, G
    Schulick, AH
    DeYoung, MB
    Dichek, DA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) : 29969 - 29977
  • [8] TRANSGENIC MICE EXPRESSING BETA-GALACTOSIDASE IN MATURE NEURONS UNDER NEURON-SPECIFIC ENOLASE PROMOTER CONTROL
    FORSSPETTER, S
    DANIELSON, PE
    CATSICAS, S
    BATTENBERG, E
    PRICE, J
    NERENBERG, M
    SUTCLIFFE, JG
    [J]. NEURON, 1990, 5 (02) : 187 - 197
  • [9] Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: Requirement of upstream sequences for control by the proximal regulatory domain
    Frenkel, B
    Montecino, M
    Green, J
    Aslam, F
    Desai, R
    Banerjee, C
    Stein, JL
    Lian, JB
    Stein, GS
    [J]. ENDOCRINOLOGY, 1996, 137 (03) : 1080 - 1088
  • [10] FUKAMIZU A, 1991, J BIOL REG HOMEOS AG, V5, P112